Atlas Trials

Salvage Therapy With High/Low Methotrexate for Loss of Response to Infliximab Dose Escalation

Clinical trial NCT02269358 · COMPLETED

Trial details

NCT number
NCT02269358
Sponsor
Prof. Arie Levine
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Crohn's Disease
Start date
2015-07-01
Primary completion
2018-10-09
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.